Get started
RocketTickers

FDA approves additional doses of Trulicity® (dulaglutide) for th

Long
Eli Lilly and Company (NYSE:LLY)  
RocketTickers  
NYSE:LLY   Eli Lilly and Company
Beyond Technical Analysis
0
0
beyondta
LLY: Eli Lilly and Company
2020-09-03 17:12:00
FDA approves additional doses of Trulicity® (dulaglutide) for the treatment of type 2 diabetes
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.